Alexandria Hammond
Stock Analyst at B of A Securities
(0.64)
# 2285
Out of 5,329 analysts
14
Total ratings
60.00%
Success rate
-1.75%
Average return
Main Sectors:
Top Industries:
| Name | Action | PT | Current | % Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
AKRO Akero Therapeutics | Upgrades: Buy | 35 63 | 44.4 | 41.89% | 2 | Jan 30, 2025 | |
REGN Regeneron Pharmaceut... | Initiates Coverage On: Outperform | 1150 | 610.09 | 88.5% | 1 | Nov 15, 2024 | |
PFE Pfizer | Initiates Coverage On: Underperform | 25 | 24.18 | 3.39% | 1 | Nov 15, 2024 | |
MRNA Moderna | Initiates Coverage On: Underperform | 40 | 27.69 | 44.46% | 1 | Nov 15, 2024 | |
MRK Merck & Co | Initiates Coverage On: Peer Perform | n/a | n/a | n/a | 1 | Nov 15, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Outperform | 1000 | 822.52 | 21.58% | 1 | Nov 15, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Outperform | 190 | 155.65 | 22.07% | 1 | Nov 15, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Outperform | 110 | 102.65 | 7.16% | 1 | Nov 15, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Peer Perform | n/a | n/a | n/a | 1 | Nov 15, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Peer Perform | n/a | n/a | n/a | 1 | Nov 15, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Outperform | 205 | 197.5 | 3.8% | 1 | Nov 15, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Underperform | 150 | 318.1 | -52.85% | 1 | Apr 22, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Assumes: Buy | 30 | 8.47 | 254.19% | 1 | Apr 22, 2024 |